Literature DB >> 29343158

Placebo Effects in Traumatic Brain Injury.

Ginger Polich1, Mary Alexis Iaccarino1,2,3, Ted J Kaptchuk4, Leon Morales-Quezada1, Ross Zafonte1,3.   

Abstract

In recent years, several randomized controlled trials evaluating pharmaceutical treatments for traumatic brain injury (TBI) have failed to demonstrate efficacy over placebo, with both active and placebo arms improving at comparable rates. These findings could be viewed in opposing ways, suggesting on the one hand failure of the tested outcome, but on the other, representing evidence of robust placebo effects in TBI. In this article, we examine several of the primary psychological processes driving placebo effects (verbal suggestion, cognitive re-framing, interpersonal interactions, conditioning, therapeutic alliance, anxiety reduction) as well as placebo neurobiology (top-down cortical regulation, reward system activation, dopaminergic and serotonergic neurotransmission). We then extrapolate from the literature to explore whether something inherent in TBI makes it particularly responsive to placebos. Viewed as such here, placebos may indeed represent a powerful and effective treatment for a variety of post-TBI complaints.

Entities:  

Keywords:  TBI; dopamine; placebo effects; reward system; verbal suggestion

Mesh:

Year:  2018        PMID: 29343158      PMCID: PMC6016098          DOI: 10.1089/neu.2017.5506

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  114 in total

1.  The powerful placebo.

Authors:  H K BEECHER
Journal:  J Am Med Assoc       Date:  1955-12-24

2.  The role of conditioning and verbal expectancy in the placebo response.

Authors:  Nicholas J Voudouris; Connie L Peck; Grahame Coleman
Journal:  Pain       Date:  1990-10       Impact factor: 6.961

3.  Commercial features of placebo and therapeutic efficacy.

Authors:  Rebecca L Waber; Baba Shiv; Ziv Carmon; Dan Ariely
Journal:  JAMA       Date:  2008-03-05       Impact factor: 56.272

4.  COMT and ANKK1 Genetics Interact With Depression to Influence Behavior Following Severe TBI: An Initial Assessment.

Authors:  John M Myrga; Shannon B Juengst; Michelle D Failla; Yvette P Conley; Patricia M Arenth; Anthony A Grace; Amy K Wagner
Journal:  Neurorehabil Neural Repair       Date:  2016-05-06       Impact factor: 3.919

5.  Mobilizing unused resources: using the placebo concept to enhance cognitive performance.

Authors:  Ulrich W Weger; Stephen Loughnan
Journal:  Q J Exp Psychol (Hove)       Date:  2012-12-13       Impact factor: 2.143

6.  Influence of context effects on health outcomes: a systematic review.

Authors:  Z Di Blasi; E Harkness; E Ernst; A Georgiou; J Kleijnen
Journal:  Lancet       Date:  2001-03-10       Impact factor: 79.321

7.  Teaching neurons to respond to placebos.

Authors:  Fabrizio Benedetti; Elisa Frisaldi; Elisa Carlino; Lucia Giudetti; Alan Pampallona; Maurizio Zibetti; Michele Lanotte; Leonardo Lopiano
Journal:  J Physiol       Date:  2016-02-24       Impact factor: 5.182

Review 8.  Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment.

Authors:  A Hróbjartsson; P C Gøtzsche
Journal:  J Intern Med       Date:  2004-08       Impact factor: 8.989

Review 9.  The placebo treatments in neurosciences: New insights from clinical and neuroimaging studies.

Authors:  Nico J Diederich; Christopher G Goetz
Journal:  Neurology       Date:  2008-08-26       Impact factor: 9.910

Review 10.  Neurobiological mechanisms of placebo responses.

Authors:  Jon-Kar Zubieta; Christian S Stohler
Journal:  Ann N Y Acad Sci       Date:  2009-03       Impact factor: 5.691

View more
  13 in total

Review 1.  Effectiveness of Pharmacotherapy for Depression after Adult Traumatic Brain Injury: an Umbrella Review.

Authors:  Amelia J Hicks; Fiona J Clay; Amelia C James; Malcolm Hopwood; Jennie L Ponsford
Journal:  Neuropsychol Rev       Date:  2022-06-14       Impact factor: 7.444

Review 2.  Neuromodulation Treatments for Mild Traumatic Brain Injury and Post-concussive Symptoms.

Authors:  Adriano Mollica; Rachel Greben; Chika Oriuwa; Shan H Siddiqi; Matthew J Burke
Journal:  Curr Neurol Neurosci Rep       Date:  2022-02-17       Impact factor: 5.081

3.  Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: a phase II blinded randomized trial.

Authors:  Wen-Chi Yang; Ya-Fang Chen; Chi-Cheng Yang; Pei-Fang Wu; Hsing-Min Chan; Jenny Ling-Yu Chen; Guann-Yiing Chen; Jason Chia-Hsien Cheng; Sung-Hsin Kuo; Feng-Ming Hsu
Journal:  Neuro Oncol       Date:  2021-03-25       Impact factor: 12.300

4.  Enhancing Self-Advocacy After Traumatic Brain Injury: A Randomized Controlled Trial.

Authors:  Lenore Hawley; Clare Morey; Mitch Sevigny; Jessica Ketchum; Grahame Simpson; Cynthia Harrison-Felix; Candace Tefertiller
Journal:  J Head Trauma Rehabil       Date:  2022 Mar-Apr 01       Impact factor: 3.117

Review 5.  Antidepressants for depression after concussion and traumatic brain injury are still best practice.

Authors:  Noah D Silverberg; William J Panenka
Journal:  BMC Psychiatry       Date:  2019-03-27       Impact factor: 3.630

Review 6.  Herbal medicine for acute management and rehabilitation of traumatic brain injury: A protocol for a systematic review.

Authors:  Boram Lee; Jungtae Leem; Hyunho Kim; Hee-Geun Jo; Sang-Hoon Yoon; Aesook Shin; Jae-Uk Sul; Ye-Yong Choi; Younghee Yun; Chan-Young Kwon
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

7.  Neural Connectivity Changes Facilitated by Familiar Auditory Sensory Training in Disordered Consciousness: A TBI Pilot Study.

Authors:  Theresa L Bender Pape; Sherri L Livengood; Sandra L Kletzel; Brett Blabas; Ann Guernon; Dulal K Bhaumik; Runa Bhaumik; Trudy Mallinson; Jennifer A Weaver; James P Higgins; Xue Wang; Amy A Herrold; Joshua M Rosenow; Todd Parrish
Journal:  Front Neurol       Date:  2020-10-08       Impact factor: 4.003

8.  Translingual Neurostimulation for the Treatment of Chronic Symptoms Due to Mild-to-Moderate Traumatic Brain Injury.

Authors:  Mitchell Tyler; Kim Skinner; Vivek Prabhakaran; Kurt Kaczmarek; Yuri Danilov
Journal:  Arch Rehabil Res Clin Transl       Date:  2019-09-27

9.  A Prospective, Multicenter Study to Assess the Safety and Efficacy of Translingual Neurostimulation Plus Physical Therapy for the Treatment of a Chronic Balance Deficit Due to Mild-to-Moderate Traumatic Brain Injury.

Authors:  Alain Ptito; Linda Papa; Kenton Gregory; Robert L Folmer; William C Walker; Vivek Prabhakaran; Rima Wardini; Kim Skinner; Michael Yochelson
Journal:  Neuromodulation       Date:  2020-04-29

10.  Amantadine Did Not Positively Impact Cognition in Chronic Traumatic Brain Injury: A Multi-Site, Randomized, Controlled Trial.

Authors:  Flora M Hammond; Mark Sherer; James F Malec; Ross D Zafonte; Sureyya Dikmen; Jennifer Bogner; Kathleen R Bell; Jason Barber; Nancy Temkin
Journal:  J Neurotrauma       Date:  2018-06-07       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.